The Thin Line Between Advertising and Misbranding with Darshan Kulkarni

Life Sciences 360

Episode 020: Harsh Thakkar (@harshvthakkar) interviews Darshan Kulkarni (@darshankulkarni), Regulatory and Compliance Attorney at The Kulkarni Law Firm.

Darshan talks about the importance of understanding how to use AI properly. He also discusses his work in advertising compliance, which involves ensuring that companies meet the labeling requirements for their products and that their promotional materials are compliant with FDA and FTC regulations.
Harsh and Darshan discuss various topics such as the use of AI in education and legal work as well as the challenges and risks associated with using AI-generated content in legal documents and journalism.
-----
Links:
* DarshanTalks
* Do you love LS 360 and want to see Harsh's smiling face? Subscribe to our YouTube channel.
-----
Show Notes:
(6:18) AI is not a good writing tool.
(8:49) The problem with lawyers and judges using ChatGPT.
(14:04) The difference between label and labeling.
(18:43) The difference between a drug and a food product.
(21:53) Dealing with regulatory inspections and the FDA.
(26:56) Responding appropriately to the FDA.
(29:47) Dealing with inspections and compliance.

For more, check out the podcast website - www.lifesciencespod.com

Bölümler

1. The Thin Line Between Advertising and Misbranding with Darshan Kulkarni (00:00:00)

2. AI is not a good writing tool. (00:06:18)

3. The problem with lawyers and judges using ChatGPT. (00:08:49)

4. The difference between label and labeling. (00:14:04)

5. The difference between a drug and a food product. (00:18:43)

6. Dealing with regulatory inspections and the FDA. (00:21:53)

7. Responding appropriately to the FDA. (00:26:56)

8. Dealing with inspections and compliance. (00:29:47)